Multivariate eQTL mapping uncovers functional variation on the X-chromosome associated with complex disease traits

Ben M Brumpton1,2, Manuel A R Ferreira3

  • 1Department of Public Health and General Practice, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Postbox 8905, MTFS, NO-7491, Trondheim, Norway. ben.brumpton@ntnu.no.

Human Genetics
|May 9, 2016
PubMed
Summary

Researchers identified 548 X-chromosome expression SNPs (eSNPs) linked to gene expression variation. Some eSNPs associate with diseases, offering insights into genetic links to human traits and conditions.

Related Concept Videos

X-linked Traits01:19

X-linked Traits

In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
59.4K
X-linked Traits01:19

X-linked Traits

7.9K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.5K
Multiple Allele Traits01:49

Multiple Allele Traits

14.9K
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
38.6K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
75